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European reports of quinolone resistance involve mostly 
Salmonella strains other than S. typhi [7,8]. 
We report a clinical failure of fluoroquinolone 
treatment, in a 45-year-old Portuguese man living in 
France, occurring 14 days after a journey in the north 
of Portugal (Braganca). The patient was admitted in 
October 1994 and gave no history of past travel outside 
Europe or recent antimicrobial treatment, particularly 
with any quinolone. Three blood cultures on admission 
were positive for S. typhi. Intravenous treatment with 
pefloxacin (800 mg/day) for 72 h, followed by 48 h of 
oral treatment with ciprofloxacin (1 g/day), had no 
effect on the patient’s fever, general condition or 
gastrointestinal signs. A blood culture was still positive 
after 48 h of pefloxacin treatment. O n  the sixth day of 
hospitalization, the appearance of hypothermia resulted 
in reassessment and modification of the treatment to 
intravenous amoxicillin (6 g/day). His temperature 
became normal within 24 h and blood culture became 
negative. Stool cultures 1 month later were negative. 
The isolates of S. typhi were lysotype A, as deter- 
mined by the French Reference Center for Salmonella 
and Shigella, Institut Pasteur, Paris. Susceptibilities were 
determined by a tube dilution method, in Mueller- 
Hinton broth with an inoculum of lo6 CFU/mL and 
incubation at  37OC for 24 h; Escherichia coli 25922 
was used as control. Those isolates were susceptible 
to ampicillin (MIC 1 pg/mL), piperacillin, cefalothin, 
cefotaxime and chloraniphenicol, but showed reduced 
susceptibility to ciprofloxacin (MIC 0.12 pg/niL) and 
pefloxacin (MIC 1 pg/mL). 
The failure of fluoroquinolone treatment has already 
been described by Umasankar et a1 [9]. A child was 
treated with ciprofloxacin orally at 20 mg/kg/day for 
10 days with no clinical improvement. The reported 
strain showed reduced susceptibility to ciprofloxacin 
(MIC 0.5 pg/mL) and resistance to nalidixic acid (MIC 
>128 pg/mL). Recent reports [10,11] suggest that in 
infection by inultiresistant strains of S. typhi which 
remain fully sensitive to fluoroquinolones, short courses 
of fluoroquinolones (of 2-5 days) are clinically effective. 
In our case, the low-grade fluoroquinolone resistance 
led to clinical failure after 5 days of fluoroquinolone 
treatment. Clinicians and microbiologists should be 
aware that this degree of reduction in susceptibility, 
which may not be demonstrated by disk testing 
with ciprofloxacin, contraindicates the use of fluoro- 
quinolones in treatment. Alternative antibiotics, such as 
chloramphenicol, amoxicillin or a third-generation 
cephalosporin, should be used. 
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Endocarditis caused by Enterococcus faecalis with high- 
level resistance to aminoglycosides: failure of ampicillin 
and ceftriaxone combined therapy 
Clin Microbiol I tz fc t  1997; 3: 577-580 
Enterococci account for 10-15%, of cases of endo- 
carditis [1,2]. Since these organisms are tolerant to cell 
wall active agents (penicillins and glycopeptides), an  
aminoglycoside must be added to these antibiotics to 
obtain synergistic bactericidal activity 11,2]. Unfor- 
tunately, enterococci with high-level resistance (HLK) 
to gentamicin and streptomycin have emerged in many 
countries in recent years, and this may create a serious 
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therapeutic problem [ 1,3-51. In fact, the combination 
of penicillins or glycopeptides with aminoglycosides 
does not act synergistically against enterococci that 
show HLR to gentamicin and streptomycin [I]. How- 
ever, although these organisms are now common, they 
have been reported in very few cases of endocarditis 
[6-111. We report here on an 86-year-old man with 
endocarditis due to an Enterococctls faeculir strain with 
HLR to gentamicin and streptomycin, who was un- 
successfully treated with various, potentially useful, 
antibiotic regimens. 
Case report 
Three weeks after a transurethral prostatectomy per- 
formed in December 1995, he developed shaking chills 
and high-grade fever that partially responded to a 
course of intramuscular piperacillin. In February 1996, 
he was admitted to a primary care hospital. Multiple 
blood cultures yielded no microbial growth, and a 
two-dimensional transthoracic echocardiogram revealed 
niitral valve regurgitation but no vegetative lesions. 
Fever subsided with a 3-week course of mero- 
penem. However, a few days after discharge the patient 
developed a new fever and was therefore admitted 
to another hospital, where multiple blood cultures 
yielded E. faeculis, and a transthoracic two-dimensional 
echocardiogram revealed a vegetative lesion on the 
anterior leaflet of the mitral valve. O n  day 6 of hospital- 
ization, the patient developed a cerebral stroke that 
eventually resolved without residual neurologic deficit. 
Fever and bacteremia proniptly subsided with a 6-week 
course of intravenous teicoplanin (7 mg/kg/day) com- 
bined with amikacin (15 mg/day) for the first 3 weeks 
of therapy. 
Two weeks after teicoplanin discontinuation, fever 
and bacteremia recurred; the patient was therefore 
treated with 12 x 106 units of intravenous penicillin 
daily for 7 weeks; despite prompt clinical response, 
following an infectious disease specialist consultation 
therapy was continued for another 4 weeks with 
30 x lo6 units of intravenous penicillin daily, admini- 
stered by continuous infusion, plus intramuscular 
gentamicin (4 mg/kg in three divided doses daily). 
Four weeks after completion of the above therapy, fever 
recurred. The patient again defervesced under oral 
ampicillin (1 g every 8 h), but after a few days of this 
therapy he was admitted to our hospital. All five blood 
cultures performed after ampicillin discontinuation 
yielded E. fueculis, which was eventually proved to 
show HLR to gentamicin and streptomycin. A two- 
dimensional transesophageal echocardiogram confirmed 
mitral regurgitation and the presence of a 1.5 x0.5 cm 
vegetative lesion on the anterior mitral leaflet. Intra- 
venous ampicillin (2 g every 4 h) was started, with 
prompt disappearance of fever and clearance of bac- 
teremia. O n  the basis of in vitro studies, 4 days later 
intravenous ceftriaxone (2 g every 12 h) was added. 
Unfortunately, on day 21 of combined antimicrobial 
therapy the patient developed high fever, cutaneous 
rash and hypotension during infusions of ceftriaxone. 
Therefore, this antibiotic was discontinued, whereas 
ampicillin was continued until completion of an 8- 
week course. 
Two weeks later the patient was still afebrile but 
one blood culture documented the relapse of the 
bacteremia caused by E. faeculis showing HLR to 
aminoglycosides. Owing to the patient’s poor general 
condition, valve replacement could not be performed. 
The patient is currently afebrile and in good clinical 
condition, and is undergoing a chronic suppressive 
domiciliary treatment with intramuscular teicoplanin. 
This was started at the dosage of 7 mg/kg every 24 h 
for the first week and then maintained with the same 
dosage twice a week. After 3 months of this therapy, 
blood cultures performed weekly before administration 
of teicoplanin have been sterile, and hematologic and 
biochemical analyses do not show any toxicity attribu- 
table to antibiotic treatment. 
Antibiotic susceptibility and serum inhibitory 
activity (SIA) and serum bactericidal activity (SBA) 
titers were investigated by the methods given in 
Venditti et al [4] and Stratton and Reller [12]. All 
E. faeculis blood isolates did not produce P-lactamase 
and showed the following identical susceptibilities to 
antibiotics: ampicillin, MIC 0.25 mg/L; penicillin, 
0.25 mg/L; teicoplanin, 0.06 mg/L; ceftriaxone, 
>64 mg/L; gentamicin, >500 mg/L; streptomycin, 
>2000 mg/L; kanamycin, >500 mg/L; tobramycin, 
>SO0 mg/L; netilmicin, >SO0 mg/L. Peak and trough 
SBA titers during therapy with ampicillin alone and 
ampicillin with ceftriaxone were 1 : 2 and < I  : 2, and 
1:16 and 1 : 16, respectively. Trough SIA and SBA titers 
during chronic suppressive therapy with teicoplanin, 
twice in a week, were 1 : 64 and <1:2, respectively. 
Table 1 shows the results of time kill studies, 
performed according to methodologies described by 
Moellering et al [13], with various concentrations of 
ampicillin and ceftriaxone alone and in combination 
against our E .  fiecalk isolate. A synergistic interaction 
was observed at the lowest concentrations (0.12 mg/L 
of ampicillin and 4 mg/L of ceftriaxone) but this 
did not result in bactericidal activity. With higher 
concentrations no synergism was observed. However, 
with the use of 20 mg/L of ampicillin in combination 
with 50 mg/L of ceftriaxone, bactericidal activity was 
documented by a 2.7Xloglo decrease in CFU count 
after 24 h. 
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Table 1 In vitro bactericidal killing of ampicillin and ceftriaxone, alone and in combination, against an ~~terococcu~fuccal is  
strain highly resistant to arninoglycosides 
Colony counts ( p a  mL) at 
Ainpicillin Ceftriaxone 
(m@) (mg/L) O h  h h  24 ti Definition of activity 
0.12 
0 
2 
0 
20 
0.12 
2 
2 
20 
0 
4 
0 
50 
0 
4 
4 
50 
50 
8 x  loi 
8x105 
8x10' 
1x106 
1 x 106 
8 x  10j 
8 ~ 1 0 ~  
8x10' 
1 x 106 
1 x 1 0 8  
1 x 10" 
2 x  105 
1 x 1010 
5x10' 
9 . 7 ~ 1 0 ~  
2.3 x 1 Os 
2.5 x 1 O5 
1 x10' 
>1x10" 
> I  XI012 
2.5 x 10' 
>1 x 10'2 
1.6X 10' 
5 . 4 ~  10' 
l . l X l 0 '  
1 x 104 
4x103 
Absent 
Absent 
Static 
Absent 
Static 
Synergistic, static 
Not synergistic, static 
Not  synergistic, static 
Not  synergistic, cidal 
Two recent surveys [4,5] have investigated further 
the prevalence of enterococci with aminoglycoside 
HLR in Italy. In a study [4] of 101 clinically significant 
isolates from inpatients of a single institution, HLR to 
at least one aminoglycoside was found in 60% of the 
cases. HLK to gentamicin and to streptomycin was 
found in 27 and 52 of the 101 enterococci, respectively. 
Even more importantly, 19 isolates had HLR to both 
gentamicin and streptomycin [4]. A multicenter study 
[5] on a 5-year collection of 163 enterococcal blood 
isolates further confirmed the above data. HLR to at 
least one aminoglycoside was again found in 60% of the 
isolates. In particular, 52% of the enterococci showed 
HLR to gentamicin, 46% HLR to streptomycin, and 
33% HLR to both aminoglycosides. These rates are 
similar to those observed in some US hospitals [l] 
but considerably higher than those reported in UK 
hospitals [3]. 
The present case further demonstrates the limitation 
of traditional cell wall active agent-aminoglycoside 
combinations: failures were observed with teicoplanin 
plus amikacin and with penicillin plus gentamicin. In 
particular, teicoplanin therapy failure was of some 
interest because this agent appeared to be ef'iicacious in 
the treatment of experimental endocarditis caused by a 
p-lactamase-producing strain of E. faecalis showing 
HLR to gentanlicin [14]. The combination ampicillin- 
ceftriaxone was investigated on the basis of recent in 
vitro evidence that the combination of a penicillin 
with a third-generation cephalosporin may result in 
potentially clinically significant bactericidal synergism 
against E.  faecalis [ 15,161. To this end, preliminary 
studies [17] in an experimental model of E. faecalis 
endocarditis have corroborated the favorable in vitro 
observations. In our case, however, even at the higher 
concentrations employed, the addition of ceftriaxone 
to ampicillin did not result in a significant synergism 
but the combination developed a slow bactericidal 
effect. The addition of ceftriaxone to ampicillin therapy 
resulted in a striking increase of SBA titers in our 
patient. Unfortunately, a serious ceftriaxone adverse 
reaction negated the chance of an adequately prolonged 
course of combined therapy. It was, however, very 
disappointing to observe a bacterenic relapse as soon as 
2 weeks after discontinuation of therapy. 
The case we have described is similar in some 
respects to those of previous reports [9,11]. Failure of 
medical therapy alone was notable in these cases, 
because it occurred despite the achievement of SBA 
titers of 1 : 64. Thus, it seems confirmed that in the case 
of gentamicin-streptomycin HLR E .  fdecufis endo- 
carditis neither excellent SBA titers nor significant 
reduction in colony counts by time kill methods 
reliably predict effectiveness of medical therapy. Due to 
poor clinical conditions, valve replacement was not 
considered to be indicated in our 86-year-old patient. 
However, even though the role of early cardiac surgery 
as an adjunct to antibiotic treatment is still not fully 
defined, persistence of the infecting strain in the 
removed valves in cases apparently cured [9,11] further 
stresses the importance of a combined medical-surgical 
therapeutic approach in patients with endocarditis 
caused by enterococci showing HLR to amino- 
glycosides. 
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Enterococcal endocarditis in a patient with a renal 
oncocytoma 
Clin Microbiol Infect 1997; 3: 58G582 
Enterococci account for 5-20% of cases of native- 
valve infective endocarditis [l-31. This incidence will 
probably increase as the population ages and more 
people are placed at risk by degenerative valve disease 
and by sources of infection such as infections of the 
genitourinary tract [4-61. Oncocytomas are benign 
neoplasms which arise in various organs, particularly 
the pancreas, thyroid and adrenals [7,8]. Their clinical 
presentation is not characteristic and sometimes they 
are found on routine ultrasound screening [8]. We 
present a patient with an enterococcal endocarditis and 
a kidney oncocytoma. 
A 72-year-old woman was admitted to the hospital 
as an emergency with severe pulmonary edema. She 
had high blood pressure but no history of major ill- 
nesses. The patient had complained of intermittent 
acute burning, right flank pain and gross painless 
hematuria in the previous 4-5 months. On occasion 
the patient had fever of 38°C and peripheral edema. 
She had been diagnosed as having a renal colic, and 
analgesics had been prescribed. Three weeks prior to 
admission she had pitting edema in the pretibial region 
and in the ankles and she complained of nocturia, 
oliguria and increasing dyspnea. One week before 
admission the patient felt fatigued and she also com- 
plained of loss of appetite. 
On admission the patient had a temperature of 
38 O C ,  the pulse was 120/min and the respirations were 
32/min. The blood pressure was 170/50 mmHg. On 
physical examination the patient appeared ill and was 
in respiratory distress. No rash or lymphadenopathy was 
found. The cardiologic examination revealed a systolic 
grade I1 murmur in the second right intercostal space 
and a holosystolic grade I11 murmur at the cardiac 
apex as well as a third sound. Pulmonary examination 
revealed disseminated crepitant rales. The abdomen was 
normal except that a mass was palpated 6 cm below 
the right costal margin and the splenic tip was palpated 
